Evaluation of concomitant methylphenidate and opioid use in patients with pain.

about

Metabolic Patterns of Fentanyl, Meperidine, Methylphenidate, Tapentadol and Tramadol Observed in Urine, Serum or Plasma.

P2860

Q39001141-BBA61440-F98B-444A-AE2D-F8358D694556

P2860

Evaluation of concomitant methylphenidate and opioid use in patients with pain.

Item

http://www.wikidata.org/entity/Q44345293

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Evaluation of concomitant methylphenidate and opioid use in patients with pain.

@en

Evaluation of concomitant methylphenidate and opioid use in patients with pain.

@nl

type

Item

label

Evaluation of concomitant methylphenidate and opioid use in patients with pain.

@en

Evaluation of concomitant methylphenidate and opioid use in patients with pain.

@nl

prefLabel

Evaluation of concomitant methylphenidate and opioid use in patients with pain.

@en

Evaluation of concomitant methylphenidate and opioid use in patients with pain.

@nl

P1476

Evaluation of concomitant methylphenidate and opioid use in patients with pain.

@en

P2093

Brookie M Best

http://www.w3.org/2001/XMLSchema#string

Candis M Morello

http://www.w3.org/2001/XMLSchema#string

Joseph D Ma

http://www.w3.org/2001/XMLSchema#string

Joy Y Jiang

http://www.w3.org/2001/XMLSchema#string

Rabia S Atayee

http://www.w3.org/2001/XMLSchema#string

P2860

Methylphenidate and its Isomers

Treatment of attention-deficit-hyperactivity disorder.

Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.

The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.

Pharmacologic treatment of opioid-induced sedation in chronic pain.

Definition of and mechanism for opioid-induced sedation.

Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.

Urine drug testing in pain medicine.

Methylphenidate: established and expanding roles in symptom management.

Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.

P304

421-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAT/BKU058

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262929025

http://www.w3.org/2001/XMLSchema#string

P698

24907143

http://www.w3.org/2001/XMLSchema#string

P921

opioid

Evaluation of concomitant methylphenidate and opioid use in patients with pain.

about

P2860

P2860

Evaluation of concomitant methylphenidate and opioid use in patients with pain.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921